Frederick Frank's most recent trade in Lifecore Biomedical Inc was a trade of 8,303 Common Stock done at an average price of $10.4 . Disclosure was reported to the exchange on Oct. 14, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lifecore Biomedical Inc | Frederick Frank | Director | Grant, award, or other acquisition of securities at price $ 10.42 per share. | 14 Oct 2020 | 8,303 | 74,327 (0%) | 0% | 10.4 | 86,517 | Common Stock |
Lifecore Biomedical Inc | Frederick Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2020 | 8,303 | 0 | - | - | Restricted Stock Unit | |
Lifecore Biomedical Inc | Frederick Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2020 | 2,200 | 0 | - | - | Restricted Stock Unit | |
Lifecore Biomedical Inc | Frederick Frank | Director | Grant, award, or other acquisition of securities at price $ 10.42 per share. | 14 Oct 2020 | 2,200 | 76,527 (0%) | 0% | 10.4 | 22,924 | Common Stock |
Lifecore Biomedical Inc | Frederick Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 8,303 | 8,303 | - | - | Right to Buy Restricted Stock Unit (RSU) | |
Lifecore Biomedical Inc | Frederick Frank | Director | Grant, award, or other acquisition of securities at price $ 10.99 per share. | 28 May 2020 | 6,000 | 66,024 (0%) | 0% | 11.0 | 65,940 | Common Stock |
Lifecore Biomedical Inc | Frederick Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 6,000 | 0 | - | - | Restricted Stock Unit |